1. Home
  2. ARDX vs WRLD Comparison

ARDX vs WRLD Comparison

Compare ARDX & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • WRLD
  • Stock Information
  • Founded
  • ARDX 2007
  • WRLD 1962
  • Country
  • ARDX United States
  • WRLD United States
  • Employees
  • ARDX N/A
  • WRLD N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • WRLD Finance: Consumer Services
  • Sector
  • ARDX Health Care
  • WRLD Finance
  • Exchange
  • ARDX Nasdaq
  • WRLD Nasdaq
  • Market Cap
  • ARDX 882.9M
  • WRLD 859.5M
  • IPO Year
  • ARDX 2014
  • WRLD 1991
  • Fundamental
  • Price
  • ARDX $5.13
  • WRLD $175.49
  • Analyst Decision
  • ARDX Strong Buy
  • WRLD
  • Analyst Count
  • ARDX 9
  • WRLD 0
  • Target Price
  • ARDX $10.50
  • WRLD N/A
  • AVG Volume (30 Days)
  • ARDX 3.0M
  • WRLD 44.4K
  • Earning Date
  • ARDX 10-30-2025
  • WRLD 10-24-2025
  • Dividend Yield
  • ARDX N/A
  • WRLD N/A
  • EPS Growth
  • ARDX N/A
  • WRLD 10.95
  • EPS
  • ARDX N/A
  • WRLD 14.92
  • Revenue
  • ARDX $386,146,000.00
  • WRLD $567,706,032.00
  • Revenue This Year
  • ARDX $17.34
  • WRLD N/A
  • Revenue Next Year
  • ARDX $27.08
  • WRLD $3.55
  • P/E Ratio
  • ARDX N/A
  • WRLD $11.95
  • Revenue Growth
  • ARDX 83.88
  • WRLD 0.80
  • 52 Week Low
  • ARDX $3.21
  • WRLD $104.99
  • 52 Week High
  • ARDX $6.84
  • WRLD $185.48
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 28.38
  • WRLD 55.81
  • Support Level
  • ARDX $5.24
  • WRLD $165.59
  • Resistance Level
  • ARDX $6.78
  • WRLD $185.48
  • Average True Range (ATR)
  • ARDX 0.20
  • WRLD 5.70
  • MACD
  • ARDX -0.15
  • WRLD -0.13
  • Stochastic Oscillator
  • ARDX 3.01
  • WRLD 57.42

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About WRLD World Acceptance Corporation

World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.

Share on Social Networks: